Fufeng Group Limited Stock Market Press Releases and Company Profile

View in Other Languages 阜丰 (HKG:0546) 与赢创携手合作生产ThreAMINO(R)(L-苏氨酸) Fufeng Group Limited (HKG:0546) and Evonik Cooperate for the Production of ThreAMINO(R) (L-Threonine) 阜豐(HKG:0546)與贏創攜手合作生產ThreAMINO(R)(L-蘇氨酸) 
and Evonik Cooperate for the Production of ThreAMINO(R) (L-Threonine)
and Evonik Cooperate for the Production of ThreAMINO(R) (L-Threonine)

Hong Kong, Jan 12, 2018 AEST (ABN Newswire) - The world's largest monosodium glutamate ("MSG") and xanthan gum producer and a major supplier for a series of bio-fermentation products, Fufeng Group Limited ("Fufeng" or the "Company", together with its subsidiaries, the "Group") (googlechartHKG:0546) and Evonik entered into a cooperation agreement for the production of ThreAMINO(R) (L-Threonine). Fufeng will manufacture ThreAMINO(R) on behalf of Evonik. The strategic partnership further strengthens Fufeng's market leadership in threonine, which is the new growth driver of Fufeng. The collaboration enables Evonik to ensure a reliable supply of L-Threonine worldwide.

"This collaboration is a good example of how two strong partners join forces. By working together, we are not only manufacturing a major animal feed amino acid, but also building the foundation for a long lasting and trusting strategic partnership." says Zhao Qiang, CEO of Fufeng.

"Our strategy reflects the recent dynamics of the feed amino acids market and helps Evonik to further optimize its bio amino acid business. The agreement with Fufeng enables us to provide our full portfolio of amino acids to all of our customers. This way, we are supporting our position in Western and Asian markets and transforming our business model by focusing on our value creating strengths in sales, services and technology. For all customers, supply security, product quality and personal contacts remain the same," says Dr. Emmanuel Auer, Head of the Animal Nutrition Business Line at Evonik.

The Junan-based Fufeng Group operates several large-scale production facilities in Northern China and counts as one of the world's largest producer of starch-based food and feed ingredients with a strong record of manufacturing fermentative feed additives. The collaboration with Evonik enables Fufeng to assume a leading role in supplying amino acids.

L-Threonine, marketed as ThreAMINO(R) by Evonik, is an essential amino acid that the body cannot produce itself. It must therefore be taken up by the animals with the feed. An optimal threonine level improves feed intake, weight gain and nutritional value of the feed. In contrast, nitrogen excretion decreases because the crude protein content of the feed is balanced according to the nutrient requirements of the animals.

Evonik has over 60 years of experience in the production of essential amino acids and provides solutions for efficient and sustainable animal nutrition to customers in over one hundred countries around the world. By expanding its range of innovative feed additives beyond amino acids, Evonik wants to make an even greater contribution to the efficiency of animal feed and create additional value for its customers. Evonik's animal nutrition products and services play a key role worldwide in producing healthy and affordable food while conserving natural resources and reducing its environmental footprint.


About Fufeng Group Limited

Fufeng Group (HKG:0546)Fufeng Group (HKG:0546) is the world's largest producer of MSG, xanthan gum and a major supplier for a series of bio-fermentation products. The main products of the Group are food additives, animal nutrition, colloid and high-end amino acids. In fiscal 2016, Fufeng generated sales of approximately RMB11.2 billion and profit attributable to shareholders of about RMB1.09 billion. For more information, please visit our website www.fufeng-group.com

abnnewswire.com 


Contact

Investors and media enquiries
Mr. Eric Yip
Vision Asia Consulting Group Limited
Mobile: 852-51186009
Office tel: 852-39066439 / Fax: 852-21809686
Email: fufeng@visionasia.com.hk



ABN Newswire
ABN Newswire This Page Viewed:  (Last 7 Days: 13) (Last 30 Days: 72) (Since Published: 8489) 

View in Other Languages 1088284896353 (25724)

googlechart